Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Cary, North Carolina Clinical Trials

A listing of Cary, North Carolina clinical trials actively recruiting patient volunteers.

RESULTS

Found (10) clinical trials

A research study is evaluating an investigational vaccine for pneumonia given with a seasonal influenza (flu) vaccine in individuals 50 years of age and older.  

Phase N/A

2.38 miles

Learn More »

North Carolina Clinical Research (NCCR) is enrolling asthmatic teens and adults for a clinical research study to evaluate an investigational inhalation medication for persistent asthma.  

Phase N/A

5.71 miles

Learn More »

North Carolina Clinical Research (NCCR) is currently enrolling children with persistent but stable asthma to take part in a pediatric asthma clinical research study to test an investigational dry powder inhaler.  

Phase N/A

5.71 miles

Learn More »

Bothered by Rosacea on Your Face? Join a clinical research study of the safety and effectiveness of an investigational spray for people with mild to moderate rosacea. Participants will use the product twice a day for eight weeks.

Phase N/A

8.06 miles

Learn More »

The VIVEVE II study is a clinical trial evaluating the Geneveve Treatment as an investigational treatment for female sexual dysfunction. This is not a commercial treatment.

8.06 miles

Learn More »

Vaginitis - Sample Collection Study Do you suspect that you or your daughter have vaginitis? If so, consider joining a clinical research study. Wake Research Associates is enrolling volunteers with vaginitis symptoms in a study testing a sample collection system.

Phase N/A

8.06 miles

Learn More »

Dry, Itchy, Red Skin? It may be Eczema! Interested in clinical research on eczema with an experimental oral medication?  

Phase N/A

8.06 miles

Learn More »

Having trouble going to the bathroom? Don’t be embarrassed — explore your options. Researchers are gathering additional information about the effectiveness of an investigational product for treating Irritable Bowel Syndrome with Constipation (IBS-C).  

Phase N/A

8.06 miles

Learn More »

A Phase 2 Study to Evaluate Once Daily Low Dose and High Dose Solabegron or Placebo Given for 12 Weeks to Treat Women With Symptoms of Overactive Bladder: Sudden Urge to Urinate Frequent Urination Associated With Wetting Episodes (VEL-2001)

This is a Phase 2b, multicenter, randomized, double-blind, placebo-controlled, parallel-group study designed to evaluate the efficacy, safety, and tolerability of solabegron modified release low dose or high dose tablets, compared to matched placebo, administered once daily for 12 weeks to adult female subjects with overactive bladder symptoms (frequency, urgency, and ...

Phase

8.06 miles

Learn More »

A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Rosacea

This is a Prospective, Vehicle Controlled, Double Blind, Multicenter, Randomized Phase II trial, comparing the effect of twice daily B244 application for 8 weeks vs. vehicle application on treatment of mild to moderate rosacea. At Screening and Baseline all subjects must have Type 1 erythematotelangiectatic rosacea (ETR). The total duration ...

Phase

8.06 miles

Learn More »